Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.
Department of Health Management, Evaluation & Policy, Université de Montréal, Montreal, Quebec, Canada.
BMJ Open. 2024 May 21;14(5):e080659. doi: 10.1136/bmjopen-2023-080659.
Intersectoral collaboration is a collaborative approach between the health sectors and other sectors to address the interdependent nature of the social determinants of health associated with chronic diseases such as diabetes. This scoping review aims to identify intersectoral health interventions implemented in primary care and community settings to improve the well-being and health of people living with type 2 diabetes.
This protocol is developed by the Arksey and O'Malley (2005) framework for scoping reviews and the Levac methodological enhancement. MEDLINE, Embase, CINAHL, grey literature and the reference list of key studies will be searched to identify any study, published between 2000 and 2023, related to the concepts of intersectorality, diabetes and primary/community care. Two reviewers will independently screen all titles/abstracts, full-text studies and grey literature for inclusion and extract data. Eligible interventions will be classified by sector of action proposed by the Social Determinants of Health Map and the conceptual framework for people-centred and integrated health services and further sorted according to the actors involved. This work started in September 2023 and will take approximately 10 months to be completed.
This review does not require ethical approval. The results will be disseminated through a peer-reviewed publication and presentations to stakeholders.
跨部门合作是卫生部门与其他部门之间的一种合作方式,旨在解决与慢性病(如糖尿病)相关的健康决定因素的相互依存性质。本范围综述旨在确定在初级保健和社区环境中实施的跨部门卫生干预措施,以改善 2 型糖尿病患者的福祉和健康。
本方案是根据 Arksey 和 O'Malley(2005 年)的范围综述框架和 Levac 方法增强版制定的。将在 MEDLINE、Embase、CINAHL、灰色文献和关键研究的参考文献中搜索,以确定任何在 2000 年至 2023 年期间发表的与跨部门性、糖尿病和初级/社区保健相关概念的研究。两名审查员将独立筛选所有标题/摘要、全文研究和灰色文献以确定是否符合纳入标准,并提取数据。合格的干预措施将按健康决定因素地图提出的行动部门和以人为中心和综合卫生服务的概念框架进行分类,并根据涉及的行为者进一步分类。这项工作于 2023 年 9 月开始,预计需要大约 10 个月完成。
本综述不需要伦理批准。结果将通过同行评审的出版物和向利益相关者的演示进行传播。